magnesium(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
magnesium(2+) — increases forced expiratory volume in one second (FEV1)
Evidence strength: very limited.Findingreplicated ×1“Greater improvements were seen in FEV1 at T0, T60 and T120 compared to TB in magnesium group (at T120, mean percentage change in FEV1 was 27.07% with magnesium versus 11.39% in the placebo group, 95%CI 3.7 to 27.7, p=0.01).”
Quoted verbatim from Intravenous magnesium sulphate as an adjuvant therapy in acute exacerbations of chronic obstructive pulmonary disease: a single centre, randomised, double-blinded, parallel group, placebo-controlled trial: a pilot study.. - Study
- RCT
- Dose
- 2 g magnesium sulphate intravenously, single infusion
- Population
- Adults presenting to the emergency department with an acute exacerbation of COPD, all receiving standard bronchodilator therapy; magnesium sulphate given intravenously versus saline
Intravenous magnesium sulphate as an adjuvant therapy in acute exacerbations of chronic obstructive pulmonary disease: a single centre, randomised, double-blinded, parallel group, placebo-controlled trial: a pilot study.2015PMID:26905985Permalink
To cite this finding: https://catalystproject.ai/e/01M5S8H755JJNKMTEBJMNSFVKV